Journals / İnönü Üniversitesi Tıp Fakültesi Dergisi / 2006 / Cilt: 13 - Sayı: 4

Psödohiperplastik prostat adenokarsinomu: Olgu sunumu

Pseudohyperplastic prostatic adenocarcinoma: A case report and review of the literature

Pages
263–267
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein we report a case of a pseudohyperplastic carcinoma and a brief review of the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pseudohyperplastic adenocarcinoma is a recently described rare type of prostatic adenocarcinoma with deceptively benign architectural features.
📊
Key Findings & Data:Pseudohyperplastic pattern mimics benign glands owing to their papillary infoldings,luminal indulations, large size and occasional corpora amylacea.
💡
Conclusion & Impact:Herein we report a case of a pseudohyperplastic carcinoma and a brief review of the literature.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pseudohyperplastic adenocarcinoma is a recently described rare type of prostatic adenocarcinoma with deceptively benign architectural features. Pseudohyperplastic pattern mimics benign glands owing to their papillary infoldings,luminal indulations, large size and occasional corpora amylacea. The main morphologic features helpful in establishing the malignancy are; nuclear enlargement, occasional to frequent nucleoli and total absence of basal cells. The diagnostic significance of this pattern lies in its potential to be misdiagnosed as benign prostate glands and adenosis. Herein we report a case of a pseudohyperplastic carcinoma and a brief review of the literature.

Özet

Psödohiperplastik prostat adenokarsinomu aldatıcı olarak benign arşitektürel özelliklere sahip bezlerle karakterize, prostat adenokarsinomunun son yıllarda tanımlanmış nadir bir varyantıdır. Psödohiperplastik patern, papiller katlantıları ve luminal düzensizlikleri olan geniş çaplı, arada corpora amylocea içeren bezler nedeniyle benign bezleri andırır. Nükleer irileşme, arada izlenebilen nükleol belirginliği ve bazal hücrelerin tamamen kaybı maligniteyi destekleyen morfolojik bulgulardır. Bu paternin bilinmesi ve tanınması, psödohiperplastik prostat adenokarsinomun, benign prostat bezleri ya da adenozis olarak yanlış tanı alma potansiyelinin bulunması nedeniyle önemlidir.

🔖

Cite This Article

ERMETE, M., ŞENGÜL, F., ÇALLI, A., SARI, A. (2022). Psödohiperplastik prostat adenokarsinomu: Olgu sunumu. İnönü Üniversitesi Tıp Fakültesi Dergisi, Cilt: 13 - Sayı: 4, 263–267. https://ajindex.com/articles/548760

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Levi AW, Epstein JI. Pseudohyperplastic prostatic adenocarcinoma on needle biopsy and simple prostatectomy. Am J Surg Pathol 2000;24(8):1039-46
  2. Humphrey PA, Kaleem Z, Swanson PE, Vollmer RT. Pseudohyperplastic prostatic adenocarcinoma. Am J Surg Pathol 1998;22(10):1239-46
  3. EG Muir. Carcinoma of the prostate. Lancet 1934;1:667-72
  4. Epstein JI. Variants of prostatic adenocarcinoma In:Prostat biopsy interpretation, New York. NY: Lippincott- Raven, 1989:169-73 5. Arista-Nasr J, Martinez-Benitez B, Valdes S, Hernandez M, Bornstein-Quevedo L. Pseudohyperplastic prostatic adenocarcinoma in transurethral resections of the prostate. Pathol Oncol Res 2003;9(4):232-5
  5. Young RH, Srigley JR, Amin MB, Ulbright TM, Cubilla AL. AFIP Atlas of Tumor Pathology, Third Series, Fascicle 28, Tumors of the Prostate Gland, Seminal Vesicles, Male Urethra, and Penis pg 140, 2000
  6. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds): WHO Classification of Tumors, Pathology and Genetics of Tumours of Urinary System and Male Genital Organs, IARC Press: Lyonn. pg 160-192, 2004
  7. Epstein JI, Young XJ. Prostate biopsy interpretation, Lippincott Williams and Wilkins, 3rd edition, pg 64-91, 2002
  8. Epstein JI, Allsbrook WC, Jr., Amin MB, Egevad LL. Update on the Gleason Grading System for Prostate Cancer: Results of an International Consensus Conference of Urologic Pathologists. Adv Anat Pathol 2006;13(1):57-9.